Pharma wins a victory over a Minnesota law designed to provide transparency into drug pricing

What's new in pharma

June 13, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Pharma wins a victory over a Minnesota law designed to provide transparency into drug pricing The trade group maintained the law, which would have required notification of drug price increases, was a "unconstitutional overreach." By Ed Silverman FDA clears Moderna's RSV vaccine for use in people aged 18 to 59 Previously, the vaccine, mResvia, was licensed for people 60 and older. Next up: Will CDC vaccine experts' recommendation for adults 50 to 59 be endorsed? By Helen Branswell STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry By Ed Silverman Adobe STAT+ | Opinion: Recursion CEO: Biotech's rainy season is not over — but we must race ahead With capital drying up and market tailwinds gone, the biotech industry — including Recursion — needs to make tactical decisions. By Chris Gibson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser